ClinicalTrials.Veeva

Menu

Acupuncture for Sleep Disruption in Cancer Survivors

Stanford University logo

Stanford University

Status

Completed

Conditions

Breast Cancer
Sleep Initiation and Maintenance Disorders

Treatments

Other: placebo
Procedure: acupuncture

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT01162018
1P30AT005886-01 (U.S. NIH Grant/Contract)
SU-04082010-5642 (Other Identifier)
BRSADJ0020

Details and patient eligibility

About

The proposed study will recruit 60 women with breast cancer who finished undergoing treatment who complain of persistent insomnia problems that began with onset of their cancer diagnosis. The eligible women would be randomized and stratified by sleep problems to two arms: (Acupuncture Arm vs. Sham Acupuncture) with a goal of having 48 patients complete the study (we anticipate about 20% attrition rate). The study interventions will begin after patients completed their treatment. The placebo control for acupuncture will be a validated sham acupuncture control Assessments will be made with daily diaries and with weekly questionnaires. PSG data will be collected on the subsample of the population. Data will be gathered via pencil-and-paper measures before, during, immediately following, one month following the completion of treatment and six months after the conclusion of treatment. In addition, actigraphy data (objective sleep continuity data) will be acquired prior to and following treatment

Enrollment

65 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Females diagnosed with breast cancer who are not currently undergoing cancer treatment (hormonal treatment is permitted).
  • The last cancer treatment ≥ 2 weeks prior to screening.
  • ≥ 21 years of age.
  • Able to understand written and spoken English.
  • Have a habitual bedtime between 9:00 pm and 3:00 am and a habitual rise time between 4:00 am and 11 am.
  • Meet DSM-IV criteria for insomnia (determined by the of the Duke Structured Interview of Sleep Disorders) with duration ≥ 1 month by Screening.
  • Willingness to discontinue the use of any current sleep aides (prescription, OTC, or naturopathic agents).
  • Properly executed Informed Consent.
  • Karnofsky Performance Scale Index score ≥ to 70, (patients who score between 61-69 might be included per PI's evaluation).
  • Insomnia Severity Index (ISI) > 8 at Screening.
  • Able to travel to Stanford University and vicinity for assessments and acupuncture treatments.

Exclusion criteria

  • Unstable medical or psychiatric illness (eMINI, current or within the last 5 years).
  • Exposure to acupuncture within 6 months prior to screening.
  • Currently pregnant or nursing.
  • History of substance abuse or meet criteria for current alcohol abuse or dependence.
  • Center for Epidemiological Studies Depression Scale (CES-D) >27 at Screening. Meet criteria for sleep apnea, restless legs syndrome or Circadian Rhythm Sleep Disorder on the basis of the Duke Structured Interview of Sleep Disorders (DSISD) or STOP-BANG is ≥ to 3.
  • Major surgery within 4 weeks prior to first acupuncture treatment.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

65 participants in 2 patient groups

Acupuncture Arm
Experimental group
Treatment:
Procedure: acupuncture
Sham Acupuncture
Sham Comparator group
Description:
Sham Acupuncture
Treatment:
Other: placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems